Streetbeat News

Analyst Ratings

CSX

Susquehanna analyst Bascome Majors maintains a Positive rating on CSX and raises the price target from $41 to $42.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:01 pm

HRMY

Harmony Biosciences (NASDAQ:HRMY) has been analyzed by 6 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $52.67, with a high of $56.00 and a low of $52.00. The company has shown strong revenue growth and profitability, but its ROE is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:01 pm

PAYX

In the past three months, analysts have shown varied sentiments towards Paychex (NASDAQ:PAYX), with most ratings being indifferent. The average 12-month price target has increased by 9.57% to $132.8. Analysts from firms like Morgan Stanley and Citigroup have raised their price targets, reflecting a positive outlook. Paychex's financials show strong revenue growth, net margin, and return on equity, indicating robust financial health.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:01 pm

ZIM

In the past three months, six analysts have provided ratings for ZIM Integrated Shipping (NYSE:ZIM), with a mix of bullish and bearish perspectives. The average 12-month price target is $18.53, slightly down from the previous $18.74. Analysts have adjusted their ratings and price targets, reflecting their views on ZIM's market performance. ZIM has shown strong revenue growth but faces challenges with net margin and debt management.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:00 pm

HAFC

Hanmi Financial (NASDAQ:HAFC) has been analyzed by four analysts, showing a range of perspectives from somewhat bullish to indifferent. The average 12-month price target has increased by 11.69% to $21.5. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Hanmi Financial faces challenges in revenue growth and return on equity but maintains a strong net margin and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:00 pm

CP

Susquehanna analyst Bascome Majors maintains a Neutral rating on Canadian Pacific Kansas (NYSE:CP) but raises the price target from $80 to $94.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:00 pm

TFIN

B. Riley Securities has reiterated a Neutral rating on Triumph Financial (NASDAQ:TFIN) and maintained a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:56 pm

ZIM

Jefferies analyst Omar Nokta has downgraded ZIM Integrated Shipping from Buy to Hold, while maintaining the price target at $25.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:55 pm

GRTS

B. Riley Securities has downgraded Gritstone Bio from Buy to Neutral and reduced its price target from $3 to $1.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:54 pm

COP

ConocoPhillips (NYSE:COP) shares rose 3.9% to $109.37 amid Middle East tensions. The company offers a 2.85% annual dividend yield, equating to $3.12 per share annually. To earn $500 monthly from dividends, an investor would need 1,923 shares, worth approximately $210,319. Analyst Neal Dingmann maintained a Buy rating but lowered the price target from $145 to $138.

Portfolio Pulse from Avi Kapoor

October 02, 2024 | 12:49 pm